Advertisement

Bilateral Facial Palsy in Wegener’s Granulomatosis

  • A. Morelló
  • A. Olmo
  • A. López Soto
  • O. Biurrun
  • J. Pérez Villa
  • F. Sabater
  • J. TraserraJr.
  • J. Traserra
Conference paper

Abstract

Peripheral facial paralysis has often been described in systemic diseases such as diabetes mellitus, hypothyroidism, periarteritis nodosa, Sarcoidosis, Takayasu’s arteritis, and Wegener’s granulomatosis (wa) [1]. However, this cranial nerve palsy occurs generally in patients with advanced disease and rarely marks the beginning of the clinical course [2]. We describe a patient who had WG with unilateral facial nerve palsy as the initial symptom. His audiogram demonstrated bilateral both air and bone conduction deficits. The evolution also involved the other side with bilateral facial palsy and he became profoundly deaf. Wegener’s granulomatosis usually presents to the otolaryngologist with nasal manifestations, but peripheral nervous system symptoms can occur by chance in the clinical onset. This disease without treatment will proceed to death, while early recognition and proper treatment can induce long-lasting remissions. Thus, it becomes necessary for head and neck clinicians to become familiar with symptoms of the initial stage of the disease since they must help secure a proper diagnosis, particularly through biopsies when indicated [3].

Keywords

Hearing Loss Facial Nerve Facial Palsy Sensorineural Hearing Loss Septal Cartilage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Power WH., (1974) Peripheral facial paralysis and systemic disease. Otolaryngol Clin North Am 7 (2): 397–405Google Scholar
  2. 2.
    Calonius I J, Christensen CK., (1980) Hearing impairment and facial palsy as initial sign of Wegener’s granulomatosis. J Laryngolotol 94: 649–657Google Scholar
  3. 3.
    Dwyer J, Janzen VD., (1981) Wegener’s granulomatosis with otological and nervous system involvement. J Otolaryngol 10 (6): 476–480PubMedGoogle Scholar
  4. 4.
    Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis: clinical, pathologica, immunologic and therapeutic considerations. Ann Intern Med 89: 660–676Google Scholar
  5. 5.
    Kornblut AD, Wolff SM, DeFries HO, Fauci AS: Wegener’s granulomatosis. Laryngoscope 90: 1453–1465Google Scholar
  6. 6.
    Luqmani RA, Jubb R, Emery P, Reid A (1991) Adu dwomoa. Inner ear deafness in Wegener’s granulomatosis. J Rheumatol 18 (5): 766–768PubMedGoogle Scholar
  7. 7.
    Schräder B (1986) Primary manifestation of Wegener’s granulomatosis of the ear with reversible sensorineural hearing loss. Laryngol Rhinol Otol 65 (1): 29–31CrossRefGoogle Scholar
  8. 8.
    Clements MR, Mistry CD, Keith AO, Ramsden RT (1989) Recovery from sensorineural deafness in Wegener’s granulomatosis, J Laryngol Otol 103: 515–518PubMedCrossRefGoogle Scholar
  9. 9.
    Yoon MD, Paparella MD (1989) Sehacherns Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 99: 600–609PubMedCrossRefGoogle Scholar
  10. 10.
    Campbell SM, Montanaro A, Bardana EJ (1983) Head and neck manifestations of autoimmune disease. Am J Otol 4: 187–216CrossRefGoogle Scholar
  11. 11.
    Steenerson RL (1986) Bilateral facial paralysis. Am J Otol 7 (2): 99–103PubMedGoogle Scholar
  12. 12.
    McGovern FH, Konigsmark BW, Sydnor JB (1972) An immunological concept for Bell’s palsy. Experimental study. Laryngoscope 82: 1594–1601Google Scholar
  13. 13.
    Kimura R, Perlman HB (1956) Extensive venous obstruction of the labyrinth. Cochlear changes. Ann Otol Rhinol Laryngol 65: 332–351Google Scholar
  14. 14.
    Rasmussen N, Wiik A, Hoier-Madsen H, Borregaard N, van der Woude FJ (1988) Antineutrophil cytoplasm antibodies, 1988. Lancet 1: 706–707PubMedCrossRefGoogle Scholar
  15. 15.
    Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85PubMedGoogle Scholar
  16. 16.
    Govett GS, Amedee RG (1990) Wegener’s granulomatosis of the head and neck. J La State Med Soc 142 (5): 13–16PubMedGoogle Scholar
  17. 17.
    Guyot JP, Baud C, Montandon P (1990) Wegener’s granulomatosis with otological disorders as primary symptoms. ORL J Otorhinolaryngol Relat Spec 52 (5): 327–334PubMedCrossRefGoogle Scholar
  18. 18.
    Kempf HG (1989) Ear involvement in Wegener’s granulomatosis. Clin Otolaryngol 14 (5): 451–456PubMedCrossRefGoogle Scholar
  19. 19.
    Colago B, Statters D (1991) Deafness and vasculitis. Lancet 337: 1602–1603Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • A. Morelló
    • 1
  • A. Olmo
    • 1
  • A. López Soto
    • 2
  • O. Biurrun
    • 1
  • J. Pérez Villa
    • 1
  • F. Sabater
    • 1
  • J. TraserraJr.
    • 1
  • J. Traserra
    • 1
  1. 1.Department of Otorhinolaryngology, Hospital ClinicFacultad de Medicina de BarcelonaBarcelonaSpain
  2. 2.Department of Internal Medicine, Hospital ClinicFacultad de Medicina de BarcelonaBarcelonaSpain

Personalised recommendations